Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy

Frontiers in Oncology

Oncology

Reza Safaralizadeh¹  Saeid Latifi-Navid²  Lixuan Wei³ 

[1]Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran

[2]Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, Iran

[3]Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States

关键词: ctDNA;    cancer therapy;    response;    monitoring;    biomarker;   

DOI  :  10.3389/fonc.2023.1210866

 received in 2023-04-23, accepted in 2023-05-23,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Latifi-Navid, Safaralizadeh and Wei